Kamila Belhocine

USPTO Granted Patents = 18 (Patent Applications = 6)

CIPO Patents = 1 (Patent Applications = 6)

EPO Patents = 10 (Patent Applications = 18)

Average Co-Inventor Count = 5.3

ph-index = 5

Forward Citations = 303(Granted Patents)

Location History:

Palo Alto, CA (US) (2016 - 2022)
Fremont, CA (US) (2019 - 2024)

Company Filing History:

Labrador Diagnostics LLC

patents

Years Active: 2016-2024

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11932899 - Methods and systems for characterizing nucleic acid molecules (2024-03-19),

2. 11767547 - Nucleic acid amplification (2023-09-26),

3. 11649487 - Nucleic acid amplification (2023-05-16),

4. 11603558 - Nucleic acid amplification (2023-03-14),

5. 11254960 - Nucleic acid amplification (2022-02-22),

6. 10745745 - Nucleic acid amplification (2020-08-18),

7. 10557158 - Processes and systems for preparation of nucleic acid sequencing libraries and libraries prepared using same (2020-02-11),

8. 10450595 - Nucleic acid amplification (2019-10-22),

9. 10428326 - Methods and systems for droplet-based single cell barcoding (2019-10-01),

10. 10400235 - Single cell analysis of transposase accessible chromatin (2019-09-03),

11. 10283217 - Systems and methods for detecting infectious diseases (2019-05-07),

12. 10221436 - Processes and systems for preparation of nucleic acid sequencing libraries and libraries prepared using same (2019-03-05),

13. 10131939 - Nucleic acid amplification (2018-11-20),

14. 9916428 - Systems and methods for detecting infectious diseases (2018-03-13),

15. 9909193 - Diagnostic methods and compositions (2018-03-06),

Title: Kamila Belhocine: Innovator in Nucleic Acid Characterization

Introduction

Kamila Belhocine is an accomplished inventor based in Palo Alto, CA, with a significant contribution to the field of molecular biology. With a total of 18 patents to her name, she has made substantial advancements in methods for characterizing nucleic acid molecules, particularly those derived from single cells. Her innovative approaches are paving the way for future breakthroughs in genetic research and diagnostics.

Latest Patents

Kamila's latest patents include groundbreaking methods and systems for characterizing nucleic acid molecules from single cells. One notable method involves providing a partition, such as droplets or wells, which contain a single cell and a single bead that comprises a nucleic acid barcode molecule. This innovative approach allows for the generation of a barcoded nucleic acid molecule used for sequencing, enabling the determination of the epigenetic state or characteristic of the nucleic acid molecule associated with that particular single cell. Additionally, she has developed methods and compositions for the amplification of nucleic acids, including techniques performed under isothermal conditions with the use of reagents like nucleic acid polymerases and primers.

Career Highlights

Throughout her career, Kamila has held influential positions at prominent companies, including Theranos, Inc. and 10x Genomics, Inc. Her work at these organizations highlights her expertise and commitment to advancing the field of microbiology and genomics.

Collaborations

Kamila has collaborated with notable peers in the industry, including Pranav Patel and Scott M Tabakman. These partnerships have enabled her to enhance her research and innovation capabilities, further contributing to her impressive portfolio of patents.

Conclusion

In conclusion, Kamila Belhocine stands out as a pioneering inventor whose contributions to nucleic acid characterization have significant implications for genetic analysis. Her innovative methodologies not only reflect her expertise but also demonstrate her commitment to pushing the boundaries of scientific research, underscoring her status as a leading figure in this essential field.

This text is generated by artificial intelligence and may not be accurate.